Nordic Pharma Announces CE Mark Approval for Lacrifill® Canalicular Gel, Paving the Way for European Launch | Eye News

Subspecialities
- Cataract
News
Events
Education Nav
Research Nav
Professional
Product Guide
The Magazine
importDebug
Login

Home >
News >
Nordic Pharma Announces CE Mark Approval for Lacrifill® Canalicular Gel, Paving the Way for European Launch

× UAT site

Website details

Cookie Policy

Data Protection Notice

Privacy Policy

Terms and Conditions

About us

About us

Contact us

Contributors

Company Awards

Get involved

Join the Community

Advertise with us

Write for us

The magazine

Accreditations

Heading